Published in Int Clin Psychopharmacol on November 01, 1995
The pharmacologic management of insomnia in patients with HIV. J Clin Sleep Med (2009) 0.87
Costs of new atypical antipsychotic agents for schizophrenia: does unrestricted access reduce hospital utilization? Healthc Policy (2007) 0.82
Effective treatment of mania with olanzapine: 2 case reports. J Psychiatry Neurosci (1997) 0.82
Blood lactate levels in patients receiving first- or second- generation antipsychotics. Croat Med J (2011) 0.77
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl (1978) 2.50
Routine nortriptyline levels in treatment of depression. Br Med J (1977) 1.82
Social functioning in depression: a review. J Clin Psychiatry (2000) 1.62
Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine. Br J Psychiatry (1997) 1.40
Recovery from depressive illness does fit an exponential model. J Clin Psychopharmacol (1996) 1.38
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol (2000) 1.31
Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord (1997) 1.21
Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Int Clin Psychopharmacol (1997) 1.06
Diarrhoea during treatment with clozapine: association with lymphocyte count. BMJ (1992) 1.02
A double blind comparison of zimelidine and amitriptyline in endogenous depression. Acta Psychiatr Scand Suppl (1981) 1.01
Pharmacological prevention of suicidal behaviour. J Affect Disord (1982) 0.97
Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial. Int J Clin Pharmacol Res (1989) 0.95
The prevention of recurrent suicidal acts. Br J Clin Pharmacol (1983) 0.93
A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Br J Psychiatry (1976) 0.93
Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. Int Clin Psychopharmacol (1998) 0.92
Profiles of antidepressant activity with the Montgomery-Asberg Depression Rating Scale. Acta Psychiatr Scand Suppl (1985) 0.89
Do some antidepressants promote suicide? Psychopharmacology (Berl) (1987) 0.89
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J Affect Disord (2000) 0.87
ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders. Eur Neuropsychopharmacol (2006) 0.87
Selective serotonin reuptake inhibitors in older patients. A tolerability perspective. Drugs Aging (1997) 0.85
Measurement of serum drug levels in the assessment of antidepressants. Br J Clin Pharmacol (1980) 0.85
Prediction of steady-state plasma concentrations and individual dosage regimens of tricyclic antidepressants from a single test dose. Ther Drug Monit (1982) 0.84
Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study. Int Clin Psychopharmacol (1995) 0.84
The antidepressant efficacy of zimelidine and maprotiline. Acta Psychiatr Scand Suppl (1981) 0.84
Development of a schizophrenia scale sensitive to change. Neuropharmacology (1978) 0.84
Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention. Eur Neuropsychopharmacol (2003) 0.83
Amitriptyline plasma concentration and clinical response. Br Med J (1979) 0.83
Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder. Int J Clin Pract (2008) 0.83
Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology. J Psychopharmacol (1993) 0.82
Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine. Int Clin Psychopharmacol (1995) 0.82
Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder. Int Clin Psychopharmacol (2001) 0.81
Lofepramine, desipramine and abnormal tests of liver function: a case report. Int Clin Psychopharmacol (1990) 0.81
Social phobia: long-term treatment outcome and prediction of response--a moclobemide study. Int Clin Psychopharmacol (1997) 0.80
Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients. Neuropharmacology (1980) 0.80
The evidence for 20mg a day of fluoxetine as the optimal dose in the treatment of depression. Br J Psychiatry Suppl (1988) 0.79
Predicting response: noradrenaline reuptake inhibition. Int Clin Psychopharmacol (1999) 0.79
Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder. Int Clin Psychopharmacol (1992) 0.79
Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine. Br J Clin Pharmacol (1983) 0.78
Cardiovascular effects of amitriptyline, mianserin and zimelidine in depressed patients. Prog Neuropsychopharmacol (1980) 0.78
Mianserin plasma levels and differential clinical response in endogenous and reactive depression. Acta Psychiatr Belg (1979) 0.78
Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients. Clin Pharmacokinet (1979) 0.78
Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients. Postgrad Med J (1980) 0.78
The prevention of suicidal acts in high-risk patients. Adv Biochem Psychopharmacol (1984) 0.77
Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. Int Clin Psychopharmacol (2002) 0.77
Benzodiazepines: time to withdraw. J R Coll Gen Pract (1988) 0.77
Clomipramine for OCD. Br J Psychiatry (1990) 0.76
Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder. J Affect Disord (1994) 0.76
An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram. Int Clin Psychopharmacol (2000) 0.76
Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Neurosci (1994) 0.76
Conduct disorder: guidelines for investigating efficacy of pharmacological intervention. Eur Neuropsychopharmacol (2003) 0.75
Pharmacological specificity is not the same as clinical selectivity. Psychopharmacol Ser (1987) 0.75
Failure to demonstrate prophylactic efficacy of dothiepin. Br J Psychiatry (1993) 0.75
Amitriptyline plasma concentrations and clinical response. Br Med J (1979) 0.75
Drug treatment of suicidal behaviour. Adv Biochem Psychopharmacol (1982) 0.75
Single dose pharmacokinetic data on zimelidine in depressed patients. Neuropharmacology (1980) 0.75
Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline. Adv Biochem Psychopharmacol (1982) 0.75
[Prevention of suicide]. Seishin Shinkeigaku Zasshi (1983) 0.75
Advances with antidepressants; clinical experiences with mianserin. Acta Psychiatr Scand Suppl (1983) 0.75
Moclobemide in the treatment of social phobia. Int Clin Psychopharmacol (1996) 0.75
The nonselective effect of selective antidepressants. Adv Biochem Psychopharmacol (1982) 0.75
Prophylactic treatment of depression. Br J Hosp Med (1994) 0.75
Managing depression in the community. Prof Nurse (1995) 0.75
[Biological basis of suicidal behavior]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1986) 0.75
The prediction of tricyclic antidepressant plasma concentrations. Postgrad Med J (1980) 0.75
Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms--a combined analysis of four British clinical trials in depression. Acta Psychiatr Scand Suppl (1983) 0.75
Has recurrent brief depression a different pharmacology. Clin Neuropharmacol (1992) 0.75
Development of new treatments for depression. J Clin Psychiatry (1985) 0.75
The nature and recurrence of RBD on placebo. Clin Neuropharmacol (1992) 0.75
Anxiety as part of depression. Acta Psychiatr Scand Suppl (1983) 0.75
Measurement of change in psychiatric illness: new obsessional, schizophrenia and depression scales. Postgrad Med J (1980) 0.75
Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial. Clin Ther (1980) 0.75
Clinical measures of rapid onset of action. Eur Psychiatry (1997) 0.75
Single oral dose pharmacokinetics of clomipramine in depressed patients. Postgrad Med J (1980) 0.75